Poly Medicure Limited · NSE:POLYMED
Poly Medicure — Q3 FY2021 Earnings Presentation
26 slides from Poly Medicure's earnings presentation, Feb 4, 2021
Slide 1: Poly Medicure Limited exchange filing cover letter
Poly Medicure Limited Regd. Office : 232-B, 3"' Floor, Okhla Industrial Estate, Phase- Ill, New Delhi - 110020 (INDIA) T:+91-ll - 33550700,47317000,F: +91-ll-26321894,26321839 P~ lY/\AED MEDICAL DEV I CES We m ,-,s We Cure E: info@polymedicure.com W: polymedicure.com CIN:L40300DL1995PLC066923 Date:
Slide 2: Poly Medicure - We Care As We Cure
P®D/MMED MEDICAL DEVICES We Care As We Cure www.polymedicure.com
Slide 3: Disclaimer
DISCLAIMER This presentation has been prepared for general information purposes in respect of Poly Medicure Limited (“Company”) together with its subsidiaries, joint ventures and associates, (together, with the “Company”, the “Group”) only, without regard to any specific objectives, suitability, fin
Slide 4: Polymed – Company Snapshot
POLYMED – COMPANY SNAPSHOT Who we are Way forward • Top exporter of plastic medical disposables/ surgical items (including syringes) in 2018 - 20191 A. Leadership Position • Robust distribution across 110+ countries with long tenured distributors as on Commercialization of current pipeline Decembe
Slide 5: Our Journey – Milestone Achievements
OUR JOURNEY…..…..MILESTONE ACHIEVEMENTS 1997 2002 2009 Commencement of JV in Egypt China Plant Manufacturing Operation 2011 2014 2016 *2020 *2021 Company New Plant at New R&D IMT Faridabad SEZ Jaipur Listed in NSE SEZ Jaipur Center expansion expansion Phase II Phase II *Work in progress 4 www.polyme
Slide 6: Corporate Structure
CORPORATE STRUCTURE POLYMED GROUP INDIA OVERSEAS Poly Medicure Poly Medicure BV - Ultra for Medical Poly Medicure Ltd (Laiyang) Co. Ltd. - Netherlands - Products Co. China - Wholly Wholly owned (UMIC) - Egypt owned Subsidiary Subsidiary Associate Plan 1 Health India Pvt. Plan 1 Health Italy Ltd. - W
Slide 7: Polymedicure in a Glance
POLYMEDICURE IN A GLANCE Reputed Indian Medical #1 Exporter of Plastic 1st Indigenous Dialyzer Devices Company Medical Disposables Manufacturer1 Among top 5 players in terms of And Surgical Items (including Established player in the operating income and syringes) Recognized By PEC, Dept category pro
Slide 8: Leadership Position as an Indian Exporter
LEADERSHIP POSITION AS AN INDIAN EXPORTER Among Top 2 Medical Devices Players in India by Revenue1 Highly Awarded and Recognized Revenue from operations (FY19) 1.5x of nearest competitor Top Exporter 48,970 Of Plastic Medical Disposables/ Surgical Items for 2018 – 2019 28,700 6,108 4,070 3,280 2,930
Slide 9: Well Entrenched Operations Across 112 Countries
WELL ENTRENCHED OPERATIONS ACROSS 112 COUNTRIES1 8 Manufacturing Plants 1 R&D Center Long tenured relationships with strategic network of distributors Distribution network with a pan-India presence included over 260 distributors1 Involved in promotion of our products in over 5,000 private and
Slide 10: Favourable Macro Indicators Provides Huge Opportunity
FAVOURABLE MACRO INDICATORS PROVIDES HUGE OPPORTUNITY India’s GDP growth to be greater than global growth Rising income levels contributing to fast growing private % growth YoY consumption expenditure in Healthcare 10.0% 6.0% 6.2% 7 Yr CAGR of 13% 4.2% 5.0% -4.0% 4.0% 3.6% 1,01,443 1,13,059 2.8% 90,
Slide 11: Understanding the Indian Medical Devices Industry
UNDERSTANDING THE INDIAN MEDICAL DEVICES INDUSTRY Overview of Medical Device Segments Snapshot of Top 6 Players Revenue from operations (FY19) Segment Coverage Key Players 3Yr -10% CAGR 48,970 165% 28,700 14% 2% 48% 1% 6,108 4,070 3,280 2,930 Disposables plastic syringes, blood bags, IV fluid Consum
Slide 12: Polymed Well Positioned for India Market Opportunities
POLYMED WELL POSITIONED FOR INDIA MARKET OPPORTUNITIES Healthcare spending needs to increase significantly to catch up to Traditionally fragmented market moving towards larger players be comparable to that of peers with superior quality Market share of players by scale of revenue (INR Mn) 2.0% 2.0%
Slide 13: High Growth Potential in Exports Market
HIGH GROWTH POTENTIAL IN EXPORTS MARKET Medical devices exports from India outpacing global market Polymed, already a leader in the largest segments, set to gain growth most from India exports market growth % Share of overall exports for various med devices segments (FY20) 5Yr CAGR of 13% vs global
Slide 14: Diversified Portfolio
DIVERSIFIED PORTFOLIO EMINENCE IN FLUID MANAGEMENT DISPOSABLES AND PROCEDURAL MEDICAL DEVICES COMPREHENSIVE PRODUCT RANGE INNOVATION, AN INTEGRAL PART OF POLYMED STORY 1st In India Oncology Infusion & Vascular Access Indigenous Dialyzer Gastroentrology Sales By Product Category (FY20) Critical Care
Slide 15: Continued Innovation Through Rich Pipeline
CONTINUED INNOVATION THROUGH RICH PIPELINE VTM & VLTM Kits Dialysis Machines N 95 Masks Pre-Filled Syringes Vial Access Spike with Valve Single use Dialyzers Blood Collection 1.4 / 1.6 / 1.8 Needles with Flashback Launched in Launched in Launched in Launched in Launched in May 2020 July 2020 Aug 202
Slide 16: Robust R&D, Regulatory and Process Capabilities
ROBUST R&D, REGULATORY AND PROCESS CAPABILITIES FULLY INTEGRATED FROM NEW PRODUCT DESIGN DEVELOPMENT TO AUTOMATED MANUFACTURING 300+ Patents & 190+ pending applications R&D Team with 35 engineers and 10 Clinical Consultants All facilities are EC certified • Regulatory team specialized Fully in
Slide 17: Manufacturing Across Four Countries
MANUFACTURING ACROSS FOUR COUNTRIES (INDIA, ITALY, EGYPT, CHINA) Well entrenched network of Indian and overseas plants. Faridabad Plant, India Haridwar Plant, India IMT Faridabad India Diverse Set of Moulding Machines and Injection Molds Automatic assembly machines with vision control systems Farida
Slide 18: Overview of Facilities
Overview of Facilities Across four countries, we ensure our product maintains standard. 17 www.polymedicure.com Confidential
Slide 19: Snapshot of Current Capacity Additions (Italy)
SNAPSHOT OF CURRENT CAPACITY ADDITIONS (ITALY) • Our stepdown subsidiary Plan1Health, Italy has expanded manufacturing capacity • Added new warehouse to facilitate increase storage and movement of goods 18 www.polymedicure.com Confidential
Slide 20: High Pedigree Management Team
HIGH PEDIGREE MANAGEMENT TEAM Mr. Devendra Raj Mehta (Chairman, Non Executive Independent Director) Mr. Himanshu Baid Mr. Rishi Baid (Managing Director) (Joint Managing Director) Mr. Jugal Kishore Baid Mrs. Mukulika Baid Dr. Shailendra Raj Mehta (Non Executive Non Independent Director) (Non Executiv
Slide 21: Executive Global Leadership Added
EXECUTIVE GLOBAL LEADERSHIP ADDED BUILDING OUT GEOGRAPHICAL LEADERSHIP Xue Wendong General Manager China • Managing Polymed China Facility Kim Schelble VP & Managing Director N. America Teo Wen Ching Regional Director Southeast Alessando Balboni Prof. Sergio Bertoglio Asia A medical professional dri
Slide 22: Premiumization Driving High Earnings Growth
PREMIUMIZATION DRIVING HIGH EARNINGS GROWTH Figures In INR Crore Net Consolidated Revenue 14.7% CAGR Net Consolidated PBT 13.9% CAGR 800 150 125.72 123.28 687.24 96.75 100.07 700 100 610.83 50 600 544.87 521.68 0 500 17-18 18-19 19-20 9m 20-21 400 Net Consolidated PAT 16.5% CAGR 300 120 95.88 92.37
Slide 23: Profitability Further Boosted by Operating Leverage
PROFITABILITY FURTHER BOOSTED BY OPERATING LEVERAGE PBT Margin (% of revenue) 25% 22.63% 20% 18.55% 18.29% 16.38% 15% 10% 5% 0% 17-18 18-19 19-20 9m 20-21 PAT Margin (% of revenue) 20% 16.95% 15% 13.53% 13.95% 10.71% 10% 5% 0% 17-18 18-19 19-20 9m 20-21 Source: Investor presentation, October 2020 22
Slide 24: 2020-2025 Vision
2020-2025 VISION WE SEEK TO TRANSITION TO A SOLUTION PROVIDER BUSINESS MODEL Started in 1997 2002-2009 2011-2019 2020-2021 2022-2025 2026 and beyond Commencement of Product and facility New R&D Center and Focus on commercial We intend to launch We aim to be a globally Manufacturing expansion further
Slide 25: Abbreviations
ABBREVIATIONS Abbreviation CAGR Compounded Annual Growth Rate Cr Crores CRISIL Report Research report on “Market assessment of the medical device industry in India” published by CRISIL in January, 2020 DoP Department of Public Health EBIT Earnings Before Interest and Tax EBITDA Earnings Before Inter
Slide 26: Thank You
Poly Medicure Limited Thank You Registered Office: 232 B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India Tel:- 91-11-33550700, 47317000, 26321838/99 For any general queries, Reach us at: info@polymedicure.com Visit: www.polymedicure.com www.polymedicure.com Confidential